Moleküler Tıp Anabilim Dalı Uluslararası Yayınları

Moleküler Tıp Anabilim Dalı Uluslararası Yayınları

 2016 

  1. Korkmaz G, Horozoglu C, Arıkan S, Gural Z, Sağlam EK, Turan S, Özkan NE, Yenilmez EN, Düzköylü Y, Doğan MB, Zeybek U, Ergen A, Yaylım İ. LGALS3 and AXIN1 gene variants playing role in the Wnt/ β-catenin signaling pathway are associated with mucinous component and tumor size in colorectal cancer. Bosn J Basic Med Sci. 2016 Feb 4;16(2):108-13 (SCI, impact factor : 0.652)
  2. Adıgüzel M, Horozoğlu C, Kılıçoğlu Ö, Özger H, Acar L, Ergen A. MMP-3 gene polymorphisms and Osteosarcoma. Indian J Exp Biol 54(3): 175-179, 2016 (SCI, impact factor : 1,16)
  3. Atalan N, Karagedik H, Acar L, Isbir S, Yilmaz SG, Ergen A, Isbir T. Analysis of Toll-like Receptor 9 Gene Polymorphisms in Sepsis. In Vivo. 2016 09-10;30(5):639-43. (SCI, impact factor : 0,974 )
  4. Ayer M., Aktuglu M.B., Acik H., Bireller E.S., Velet M., Kirkizlar O., et al., “Cox-2 gene polymorphisms in Turkish patients with myelodysplastic syndrome”, International Journal Of Clinical And Experimental Medicine, vol.9, pp.10597-10601, 2016 SCI-ex, impact factor :1,075
  5. Celik R, Bireller ES, Kucukali CI, Tuzun E, Cakmakoglu B. Investigation of DNA Repair Genes in Patients with Obsessive Compulsive Disorder. Advances in Clinical and Experimental Medicine. Initially Accepted: January 2016.  (SCI-ex, impact factor : 1.127)
  6. Coskun C, Verim A, Farooqi AA, Turan S, Mezani B, Kucukhuseyin O, Tolgahan Hakan M, Ergen A, Yaylim I. Are there possible associations between MnSOD and GPx1 gene variants for laryngeal cancer risk or disease progression? Cell Mol Biol (Noisy-le-grand). 2016 Apr 30;62(5):25-30. (SCI, impact factor : 0,691)
  7. Dasdemir S, Kucukali C, Bireller E, Tuzun E, Cakmakoglu B.  Chemokine gene variants in schizophrenia. Nord J Psychiatry. 2016 Aug;70(6):407-12. SCI-ex, impact factor 1.273
  8. Farooqi AA, Fayyaz S, Shatynska-Mytsyk I, Javed Z, Jabeen S, Yaylim I, Gasparri ML, Panici PB Is miR-34a a Well Equipped swordsman to Conquer Temple of Molecular Oncology? Chem Biol Drug Des. 2016 Aug 11. doi: 10.1111/cbdd.12634. (SCI, impact factor : 2,802)
  9. Ikitimur-Armutak EI, Ulukaya E, Gurel-Gurevin E, Yaylim I, Isbilen-Basok B, Sennazli G, Yuzbasioglu-Ozturk G, Sonmez K, Celik F, Kucukhuseyin O, Korkmaz G, Yilmaz VT, Zeybek SU. Apoptosis-inducing Effect of a Palladium(II) Complex-[PdCl(terpy)](sac).2H2O] on Ehrlich Ascites Carcinoma (EAC) in Mice. In Vivo. 2016 Jul-Aug;30(4):457-64. PubMed PMID: 27381609. (SCI, impact factor : 0,832)
  10. Isitmangil G, Gurleyik G, Aker FV, Coskun C, Kucukhuseyin O, Arikan S, Turan S, Talu CK, Dogan MB, Farooqi AA, Yaylim I. Association of CTLA4 and CD28 Gene Variants and Circulating Levels of Their Proteins in Patients with Breast Cancer. In Vivo. 2016 Jul-Aug;30(4):485-93. PubMed PMID: 27381613. (SCI, impact factor : 0,832)
  11. Kanca D, Gormus U, Tokat B, Eronat AP, Bugra Z, Ozturk O, Yilmaz-Aydogan H. Additive Antiatherogenic Effects of CETP rs708272 on Serum LDL Subfraction Levels in Patients with CHD Under Statin Therapy. Biochem Genet. 2016 Nov, 1-15, doi:10.1007/s10528-016-9782-5 (SCI, impact factor : 0,952)
  12. Korkmaz G, Horozoglu C, Arıkan S, Gural Z, Sağlam EK, Turan S, Özkan NE, Kahraman OT, Yenilmez EN, Düzköylü Y, Doğan MB, Zeybek U, Ergen A, Yaylim I. LGALS3 and AXIN1 gene variants playing role in the Wnt/β-catenin signaling pathway are associated with mucinous component and tumor size in colorectal cancer. Bosn J Basic Med Sci. 2016 Feb 4;16(2):108-13. (impact faktör: 0.652)
  13. Kucukhuseyin O, Ozgen T, Karagedik EH, Cesur Y, Yilmaz Aydogan H, Yaylim I, Ergen HA. The effects of Advanced Glycation End Products (RAGE)-374T/A and Gly82Ser variants and soluble-RAGE levels to obesity in children. Cell Mol Biol (Noisy-le-grand). 2016 Apr 30;62(5):9-14. (SCI, impact factor : 0,650)
  14. Kurnaz-Gömleksiz Ö, Kucukhuseyin O, Ozkok E, Bugra Z, Ozturk O, Yilmaz-Aydogan H. Are IVS4 SNPs of OLR1 Gene associated with coronary artery disease: Is there a linkage between IVS4 SNPs? Advances in Clinical and Experimental Medicine, Basımda (SCI- Expanded, impact factor : 1,127).
  15. Kurnaz-Gömleksiz Ö, Tokat B, Aslan EI, Yanar F, Ermiş-Karaali Z, Öztürk O, Yilmaz-Aydoğan H. Can rs3767140 SNP of the perlecan (HSPG2) gene affect the diabetes mellitus through the dyslipidemia? Cell Mol Biol (Noisy-le-grand). 2016;62(8):35-9. SCI, impact factor : 0,94)
  16. Lin X, Aslam A, Attar R, Yaylim I, Qureshi MZ, Hasnain S, Qadir MI, Farooqi AA. Signaling lansdscape of prostate cancer. Cell Mol Biol (Noisy-le-grand). 2016 Jan 19;62(1):45-50. Review. PubMed PMID: 26828986 . (SCI, impact factor : 0,650)
  17. Lin X, Qureshi MZ, Attar R, Khalid S, Tahir F, Yaqub A, Aslam A, Yaylim I, De Carlos Back LK, Farooqi AA, Ismail M. Targeting of BCR-ABL: Lessons learned from BCR-ABL inhibition. Cell Mol Biol (Noisy-le-grand). 2016 Oct 31;62(12):129-137. doi: 10.14715/cmb/2016.62.12.22. PubMed PMID: 27894413. (SCI, impact factor : 0,650)
  18. Odemis S, Tuzun E, Gulec H, Semiz UB, Dasdemir S, Kucuk M, Yalcınkaya N,Bireller ES, Cakmakoglu B, Küçükali CI. Association Between Polymorphisms of DNA Repair Genes and Risk of Schizophrenia. Genet Test Mol Biomarkers. 2016 Jan;20(1):11-7. doi: 10.1089/gtmb.2015.0168 SCI-ex, impact factor  297
  19. Pehlivan S, Mehmet Atilla Uysal, Tülin Çagatay, Cigdem Keklik Cinar, Feyza Erkan, Ulgen Sever, ZuleyhaBingol, Mustafa Pehlivan, Sadrettin Pençe, Yedikule SmokingCessationStudyGroup. Analysis of CYP2A6 and CYP2A13 genesusingnewgenerationsequencingmethod in smokersandnon-smokers. EuropeanRespiratoryJournal 2016 48: OA1485; DOI: 10.1183/13993003. (SCI, impactfactor: 8,332).
  20. Pençe S, Özbek E, Ozan Tiryakioğlu N, Ersoy Tunali N. Deregulation of seven CpGisland-harboringmiRNAs in bladdercancer: miR-155 and miR-23b as themostpromisingoncomiRs. 2016 Mar 20;62(3):25-30. (SCI, impactfactor : 0,94)
  21. Sarica K, Kafkasli A, Narter F, Ozturk O, Yazici O, Hamarat B, Sahin C, Eryildirim B.Urolithiasis. 2016 Hyperoxaluria-induced tubular ischemia: the effects of verapamil on the antioxidant capacity of the affected kidneys. Nov;44(6):509-519. (SCI, impact factor : 1.454)
  22. Sezer Zhmurov Ç, Timirci-Kahraman Ö, Amadou FZ, Fazlıoğulları O, Başaran C, Catal T, Zeybek Ü, Bermek H. Expression of Egfl7 and miRNA-126-5p in Symptomatic Carotid Artery Disease. Genet Test Mol Biomarkers. 2016 Mar;20(3):125-9 (impact faktör: 1.297)
  23. Tokac D, Tuzun E, Gulec H, Yılmaz V, Bireller ES, Cakmakoglu B, Kucukali CI. Chemokine and Chemokine Receptor Polymorphisms in Bipolar Disorder. Psychiatry Investig. 2016 Sep;13(5):541-548 SCI-ex, impact factor 1.5
  24. Topaloglu M, Tuzun E, Gulec H, Bireller ES, Cakmakoglu B, Kucukali CI. Neuronal Nitric Oxide Synthase Polymorphisms in Obsessive-Compulsive Disorder. Nord J Psychiatry. 2016 Oct 14:1-5. SCI-ex, impact factor 1.273
  25. Toydemir-Karabulut TSF, Inal-Gültekin G, Ateş A, Turna-Yilmaz Ö, Enginler SÖ, Kirşan I, Erdoğan-Bamaç Ö, Arun SS, Demirtaş B. Effects of pyometra on some oxidative stress parameters, inflammatory mediators and neutrophil segmentation in bitches. Vet Dergi Kafkas. 2016;22(6): 837-846 (SCI-ex, impact factor : 0,418)
  26. Tüzüner MB, Öztürk T, Eronat AP, Seyhan F, Kısakesen Hİ, Calay Z, İlvan Ş, Turna H, Yılmaz-Aydoğan H, Bermek H, Öztürk O. Evaluation of Local CYP17A1 and CYP19A1 Expression Levels as Prognostic Factors in Postmenopausal Invasive Ductal Breast Cancer Cases. Biochem Genet. 2016;54(6):784-802. (SCI, impact factor : 0,952)
  27. Yanar K, Çakatay U, Aydın S, Verim A, Atukeren P, Özkan NE, Karatoprak K, Cebe T, Turan S, Ozkök E, Korkmaz G, Cacına C, Küçükhüseyin O, Yaylım I. Relation between Endothelial Nitric Oxide Synthase Genotypes and Oxidative Stress Markers in Larynx Cancer. Oxid Med Cell Longev. 2016;2016:4985063. doi: 10.1155/2016/4985063. (SCI, impact factor : 4,492)
  28. Yilmazer N, Coskun C, Gurel-Gurevin E, Yaylim I, Eraltan EH, Ikitimur-Armutak Antioxidant and Anti-inflammatory Activities of a Commercial Noni Juice revealed by Carrageenan-induced Paw Edema. Pol J Vet Sci. 2016 Sep 1;19(3):589-595. doi: 10.1515/pjvs-2016-0074. PubMed PMID: 27760029. (SCI, impact factor : 0,719)

 

 

2015

  1. Gok O, Karaali ZE, Acar L, Kilic U, Ergen A. Can. ABCG5 and ABCG8 Gene Polymorphisms in Type 2 Diabetes Mellitus in the Turkish Population. J Diabetes. 2015 Jun 16. pii: S1499-2671(15)00394-9.
  2. Cacina C, Arikan S, Düzköylü Y, Doğan MB, Okay E, Turan S, Yaylim I, Isbir T. Analyses of EGF A61G Gene Variation and Serum EGF Level on Gastric Cancer Susceptibility and Clinicopathological Parameters. Anticancer Res. 2015 May;35(5):2709-13.
  3. Cacina C, Pence S, Turan S, Genc F, Ozdemir H, Kafadar A, Kaynar MY, Yaylim I. Analysis of CASP8 D302H Gene Variants in Patients with Primary Brain Tumors. In Vivo. 2015 Sep-Oct;29(5):601-4.
  4. Birsu Cincin Z, Unlu M, Kiran B, Sinem Bireller E, Baran Y, Cakmakoglu B. Anti-proliferative, apoptotic and signal transduction effects of hesperidin in non-small cell lung cancer cells. Cell Oncol (Dordr). 2015 Apr 10. DOI 10.1007/s13402-015-0222-z
  5. Odemis S, Tuzun E, Gulec H, Semiz UB, Dasdemir S, Kucuk M, Yalcınkaya N,Bireller ES, Cakmakoglu B, Küçükali CI. Association Between Polymorphisms of DNA Repair Genes and Risk of Schizophrenia.             Genet Test Mol Biomarkers. 2015 Nov 10.
  6. Kurt-Sirin O, Yilmaz-Aydogan H, Uyar M., Seyhan MF,  Isbir T, Can A. Association between β3-adrenergic receptor (ADRB3) gene polymorphism with body mass index and bone mineral density in Turkish postmenopausal women. Journal of Faculty Pharmacy of Istanbul University, 2015; 45(1):7-18
  7. Ozturk T, Toptaş- Hekimoglu B, Eronat AP, Saygılı N, Daglar-Aday A, Bassullü N, Turkmen I, Yilmaz Aydoğan H, Bulbul G, Süha Goksel S, Ozturk O,  İsbir T. Co-existence of BRAF V600E Gene Mutation in Tumor and Non-Ttumoral Surrounding Tissues of in Colorectal Cancer       Invivo (Basımda)
  8. Ozdemircan A, Dasdemir S, Kucukali CI, Bireller ES, Ozturk H, Cakmakoglu B. COX-2 gene variants in bipolar disorder-I. Psychiatr Danub. 2015 Dec;27(4):385-9.
  9. Nalkiran I, Turan S, Arikan S, Kahraman ÖT, Acar L, Yaylim I, Ergen A. Determination of Gene Expression and Serum Levels of MnSOD and GPX1 in Colorectal Cancer. Anticancer Res. 2015 Jan;35(1):255-9
  10. Ali Kafadar, Özlem Küçükhüseyin, Saime Turan, Ezgi Nurdan Yenilmez, Servet Tunoglu, Umit Zeybek, Mehmet Yasar Kaynar, Rahsan Kemerdere, Ilhan Yaylim. Distribution and Effects of CDKN2 p16 540 C>G and 580 C>T, and MDM2 SNP309 T>G Polymorphisms in Patients with Primary Brain Tumors. Anticancer Research 2015; 35(7):3933-3942. Impact factor :1,656 (SCI-ex)
  11. Farooqi AA, Fayyaz S, Shatynska-Mytsyk I, Javed Z, Jabeen S, Yaylim I, Gasparri ML, Panici PB Is miR-34a a Well Equipped swordsman to Conquer Temple of Molecular Oncology?Chem Biol Drug Des. 2015 Aug 11. doi: 10.1111/cbdd.12634.indi
  12. Narter F, Bireller ES, Engin C, Catmakas T, Narter F, Ergen A, Cakmakoglu B. Distribution of monocyte chemoattractant protein-1 (MCP-1 A-2518G) and chemokine receptor (CCR2-V64Ι) gene variants in hyperbilirubinemic newborns. Int J Clin Exp Med. 2015 Aug 15;8(8):14075-9.
  13. Ilhan M, Kahraman OT, Turan S, Turgut S, Karaman O, Zeybek U, Shukurov S, Yaylim I, Tasan E. Does DRD2 polymorphism influence the clinical characteristics of prolactinoma? Ann Endocrinol (Paris). 2015 Oct;76(5):614-9.
  14. Sivrikoz E., Timirci-Kahraman Ö, Ergen A., Zeybek Ü., Aksoy M., Yanar F., İsbir T., Kurtoğlu M. Gene Expression Levels of Elastin and Fibulin-5 According to the Differences Between Carotid Plaque Regions. In Vivo, Mar-Apr;29(2):229-35.
  15. Timirci-Kahraman O, Ozkan NE, Turan S, Farooqi AA, Verim L, Ozturk T, Inal-Gultekin G, Isbir T, Ozturk O, Yaylim I. Variants in the Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) and Death Receptor (DR4) Genes Contribute to Susceptibility to Bladder Cancer. Genet Test Mol Biomarkers. 2015 May 8.
  16. Ozlem Timirci-Kahraman, Nazli Ezgi Ozkan,Turan Saime,Ammad Ahmad Farooqi,Levent Verim,Tulin Ozturk,Inal Gültekın Güldal,Turgay Isbir,Öztürk Oguz, Yaylım Ilhan. Genetic Variants in the Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Death Receptor Genes Contribute to Susceptibility to Bladder Cancer. Genetic Testing and Molecular Biomarkers, 19(6), 309-315.
  17. Umman B, Cakmakoglu B, Cincin ZB, Kocaaga M, Emet S, Tamer S, Gokkusu C. Identification of gene variants related to the nitric oxide pathway in patients with acute coronary syndrome.       2015 Dec 10;574(1):76-81. doi: 10.1016/j.gene.2015.07.081.
  18. Ilhan M, Toptas-Hekimoglu B, Yaylim I, Turgut S, Turan S, Karaman O, Tasan E. Investigation of the vitamin D receptor polymorphisms in acromegaly patients. Biomed Res Int. 2015;2015:625981.
  19. Gultekin GI, Yilmaz SG, Kahraman OT, Atasoy H, Dalan AB, Attar R, Buyukoren A, Ucunoglu N, Isbir T. Lack of Influence of the ACE1 Gene I/D Polymorphism on the Formation and Growth of Benign Uterine Leiomyoma in Turkish Patients. Asian Pac J Cancer Prev. 2015;16(3):1123-7
  20. Attar , S. Tabassum , S. Fayyaz , M. S. Ahmad , D. R. Nogueira , I. Yaylim , O. Timirci-Kahraman O. Kucukhuseyin, C. Cacina, A. A. Farooqi and M. Ismail. Natural products are the future of anticancer therapy: Preclinical and clinical advancements of Viscum album phytometabolites. Cell. Mol. Biol. 2015; 61 (6): 62-68.
  21. Pence, Ozbek E, Tiryakioğlu O. Ersoy N. Pence H H. Oncomir expression in bladder cancer: dysregulation of seven microRNAs in relation with disease stage. Cancer Investigation (In Press). 2015.”
  22. Atasoy H, Güleç Yılmaz S, Ergen A, Görmüş U, Küçükhüseyin Ö, Dalan AB, Kusat Ol K, Öğüt DB, Güleç H, Çetin B, Timirci Kahraman Ö, Ömerci B, Uçunoğlu N, İnal Gültekin G, İsbir T. Paraoxonase1 192 (PON1 192) Gene Polymorphism and Serum Paraoxonase Activity in Panic Disorder Patients. In Vivo. 2015;29(1):51-54.
  23. Kunt AT, Isbir S, Gormus U, Kahraman OT, Arsan S, Yilmaz SG, Isbir T. Polymorphisms of MMP9 and TIMP2 in Patients with Varicose Veins In Vivo. 29(4):461-5
  24. Düzköylü Y, Arıkan S, Turan S, Yaylım İ, Doğan MB, Sarı S, Ersöz F, Zeybek Ü, Tımırcı Kahraman Ö, Çelikel B, Erdem S. Possible relationship between the resistin gene C-420G polymorphism and colorectal cancer in a Turkish population. Turk J Gastroenterol.26(5):392-6
  25. Tulin Ozturk, Ozlem Kucukhuseyin, Allison Pınar Eronat, Mete Bora Tuzuner, Aynur Daglar-Aday, Neslihan Saygili, Halil Ibrahim Kisakesen, Fatih Seyhan, Mehmet Velidedeoğlu, Zerrin Calay, Şennur İlvan, Hülya Yılmaz-Aydoğan and Oguz Ozturk Turgar İsbir. Preliminary Study: Prominent miRNAs of Breast Malignant Tissues Compared to Normal Tissues in Turkish Patients with Breast Cancer . Anticancer Research 2015; 35(10):5425-5432.
  26. Tüzün E, Küçükhüseyin Ö, Kürtüncü M, Türkoğlu R, Yaylım İ. Reduced serum vitamin D levels in neuromyelitis optica. Neurol Sci. 2015 Apr 25. [Epub ahead of print] DOI: 10.1007/s10072-015-2229-7
  27. Ozlem Kucukhuseyin, Bahar Toptas, Ozlem Timirci-Kahraman, Selim Isbir, Kubilay Karsidag, Turgay Isbir. The Effect of GHR/exon-3 polymorphism and serum GH, IGF-1 and IGFBP-3 levels on diabetes and coronary heart disease. In Vivo 2015; 29(3):371-378.
  28. Attar R, Atasoy H, Inal-Gültekin G, Timirci-Kahraman Ö, Güleç-Yilmaz S, Dalan AB, Yildirim G, Ergen A, Isbir T. The Effects of PON1 Gene Q192R Variant on the Development of Uterine Leiomyoma in Turkish Patients. T In Vivo. 2015 03-04;29(2):243-246.
  29. Karaali, Z., Cincin, Z.B., Bireller, E.S., Cakmakoglu, B., Akmansoy, H.N., Aktuglu, M.B., Yigit, N., Velet, M., Alioglu, T., Civilibal, M., Sarilar, O. The Sociodemographic Features of Home Health Care Patients: Turkey, Istanbul Haseki Training and Research Hospital, 2011-2013. Jokull, 2015, 65(9):116-124.
  30. Attar Rukset,Atasoy Hande,Inal Gültekın Güldal,Tımırcı Kahraman Özlem,Güleç Yılmaz Seda,A Burak Dalan,Yıldırım G,Ergen Hayrıye Arzu,Isbır Turgay. The effects of PON1 gene Q192R variant on the development of uterine leiomyoma in Turkish patients. Iv Vivo, 29(2), 243-246
  31. Kucukhuseyin O, Turan S, Yanar K, Arikan S, Duzkoylu Y, Aydin S, Cakatay U, Mezani B, Farooqi AA, Isitmangil GA, Kiran B, Cacina C, Yenilmez EN, Ergen A, Zeybek U, Yaylim I. Individual and Combined Effects of CTLA4-CD28 Variants and Oxidant-Antioxidant Status on the Development of Colorectal Cancer. Anticancer Res, 2015; Oct; 35(10):5391-400
  32. Ermis A, Erkiran M, Dasdemir S, Turkcan AS, Ceylan ME, Bireller ES, Cakmakoglu B. The relationship between catechol-O-methyltransferase gene Val158Met (COMT)polymorphism and premorbid cannabis use in Turkish male patients with schizophrenia. In Vivo. 2015 Jan-Feb;29(1):129-32.
  33. Karakose Okyaltırık F, Rezvani A, Turan S, Uysal Ö, Yakar F, Sozgen H, Ozkan NE, Akkoyunlu ME, Bayram M, Kutbay Ozcelik H, Sezer M, Guler M, Yaylım İ, Kart L. 
    Relationship of CTLA4 and CD28 polymorphisms with lung involvement, HRCT findings and pulmonary function tests in Turkish patients with ankylosing spondylitis.
    Clin Respir J. 2015 Sep 14. doi: 10.1111/crj.12388.
  34. Coskunpınar, P. Yıldız, E. Aynacı,  A. Turna, Y. Musterı Oltulu, E. Hekımoglu, T. Isbır, I. Yaylım. Investigation of some DNA repair genes association in non small cell lung cancer.Cell Mol Biol (Noisy-le-grand). 2015 DECEMBER 19;61(8): 57-62
  35. Timirci-Kahraman O, Ozkan NE, Turan S, Farooqi AA, Verim L, Ozturk T, Inal-Gultekin G, Isbir T, Ozturk O, Yaylim I. Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand and death receptor genes contribute to susceptibility to bladder cancer.Genet Test Mol Biomarkers. 2015 Jun;19(6):309-15. doi: 10.1089/gtmb.2015.0050. Epub 2015 May 8

 

2014

  1. Ergen A, Karagedik H, Karaali ZE, Isbir T. An association between MPO -463 G/A polymorphism and type 2 diabetes. Folia Biol (Praha). 2014;60(3):108-12. (IF:1,219)
  2. Verim L, Timirci-Kahraman O, Akbulut H, Akbas A, Ozturk T, Turan S, Yaylim I,  Ergen A, Ozturk O, Isbir T. Functional genetic variants in apoptosis-associated FAS and FASL genes and risk of bladder cancer in a Turkish population. In Vivo. 2014 May-Jun;28(3):397-402.
  3. Görmüs U, Timirci-Kahraman O, Ergen A, Kunt AT, Isbir S, Dalan AB, Isbir T. Expression levels of elastin and related genes in human varicose veins. Folia Biol (Praha). 2014;60(2):68-73.
  4. Dalan AB, Timirci-Kahraman O, Turan S, Kafadar AM, Yaylim I, Ergen A, Gormus U, Gulec-Yilmaz S, Kaspar C, Isbir T. Association between FAS and FASL genetic variants and risk of primary brain tumor. Int J Neurosci. 2014 Jun;124(6):443-9.
  5. Sozen S, Horozoglu C, Bireller ES, Karaali Z, Cakmakoglu B. Association of SUMO4 M55V and -94ins/del gene variants with type-2 diabetes. In Vivo. 2014 Sep-Oct;28(5):919-23.
  6. Cincin ZB, Unlu M, Kiran B, Bireller ES, Baran Y, Cakmakoglu B. Molecular mechanisms of quercitrin-induced apoptosis in non-small cell lung cancer. Arch Med Res. 2014 Aug;45(6):445-54.
  7. Orhan KS, Coskunpinar E, Kanliada D, Oltulu YM, Basaran B, Celik M, Cakmakoglu B, Deger K. Investigation of the association of hRRM1 and p53R2 gene polymorphisms in head and neck squamous cell carcinomas. Med Oncol. 2014 Jul;31(7):12.
  8. Cetinkaya Y, Dasdemir S, Gencer M, Bireller ES, Ozkok E, Aydin M, Cakmakoglu B. DNA repair gene variants in migraine. Genet Test Mol Biomarkers. 2014 Aug;18(8):568-73.
  9. Aktuglu MB, Ayer M, Bireller ES, Rencuzogullari C, Acik H, Karaali Z, Alioglu T, Yigit N, Velet M, Atalay E, Ure OS, Cakmakoglu B. Investigation of DNA repair gene variants on myelodysplastic syndromes in a Turkish population. Med Oncol. 2014 Oct;31(10):174.
  10. Solmaz S, Adan Gokbulut A, Cincin B, Ozdogu H, Boga C, Cakmakoglu B, Kozanoglu I, Baran Y. Therapeutic potential of apigenin, a plant flavonoid, for imatinib-sensitive and resistant chronic myeloid leukemia cells. Nutr Cancer. 2014;66(4):599-612.
  11. Tanis T, Cincin ZB, Gokcen-Rohlig B, Bireller ES, Ulusan M, Tanyel CR, Cakmakoglu B. The role of components of the extracellular matrix and inflammation on oral squamous cell carcinoma metastasis. Arch Oral Biol. 2014 Nov;59(11):1155-63.
  12. Cincin ZB, Unlu M, Kiran B, Bireller ES, Baran Y, Cakmakoglu B. Apoptotic Effects of Quercitrin on DLD-1 Colon Cancer Cell Line. Pathol Oncol Res. 2014 Aug 6. [Epub ahead of print].
  13. Kurt-Sirin O, Yilmaz-Aydogan H, Uyar M, Seyhan MF, Isbir T, Can A. Combined effects of collagen type I alpha1 (COL1A1) Sp1 polymorphism and osteoporosis risk factors on bone mineral density in Turkish postmenopausal women. Gene. 2014 May 1;540(2):226-31.
  14. Nogueira DR, Yaylim I, Aamir Q, Kahraman OT, Fayyaz S, Kamran-ul-Hassan Naqvi S, Farooqi AA. TRAIL mediated signaling in pancreatic cancer. Asian Pac J Cancer Prev. 2014;15(15):5977-82.
  15. Gulec-Yılmaz S, Gulec H, Dalan AB, Cetın B, Tımırcı-Kahraman O, Ogut DB, Atasoy H, Dırımen GA, Gultekın GI, Isbır T.The relationship between ACE polymorphism and panic disorder. In Vivo. 2014 Sep-Oct;28(5):885-9.

 

 

2013

 

  1. Tuna G, Küçükhüseyin O, Arıkan S, Kaytan Sağlam E, Güler E, Cacına C, Oztop O, Turan S, Korkmaz G, Yaylım I. Do CDKN2 p16 540 C>G, CDKN2 p16 580 C>T, and MDM2 SNP309 T>G Gene Variants Act on Colorectal Cancer Development or Progression?DNA Cell Biol. 2013 Jul;32(7):400-8. doi: 10.1089/dna.2012.1933. Epub 2013 Jun 18. PMID: 23777425
  2. Haytural H, Yalcinkaya N, Akan G, Arikan S, Ozkok E, Cakmakoglu B, Yaylim I, Aydin M, Atalar F. Identification of a Novel BRCA2 and CHEK2 A-C-G-C Haplotype in Turkish Patients Affected with Breast Cancer.Asian Pac J Cancer Prev. 2013;14(5):3229-35. PMID: 23803109
  3. Toptaş B, Kafadar AM, Cacina C, Turan S, Yurdum LM, Yiğitbaşı N, Gökçe MO, Zeybek U, Yaylım I. The vitamin D receptor (VDR) gene polymorphisms in Turkish brain cancer patients.Biomed Res Int. 2013;2013:295791. doi: 10.1155/2013/295791. Epub 2013 Apr 17. PMID: 23691496
  4. Verim L, Toptas B, Ozkan NE, Cacina C, Turan S, Korkmaz G,Yaylim I. Possible Relation between the NOS3 Gene GLU298ASP Polymorphism and Bladder Cancer in Turkey.Asian Pac J Cancer Prev. 2013;14(2):665-8. Epub 2011 Jun 25. PMID: 21706163
  5. Bektas-Kayhan K, Unür M, Yaylim-Eraltan I, Ergen HA, Toptas B, Hafiz G, Karadeniz A, Isbir T. Association of vitamin D receptor Taq I polymorphism and susceptibility to oral squamous cell carcinoma.In Vivo. 2010 Sep-Oct;24(5):755-9. PMID: 20952745
  6. Zeybek U, Yaylim I, Ozkan NE, Korkmaz G, Turan S, Kafadar D, Cacina C, Kafadar AM. Cyclin D1 Gene G870A Variants and Primary Brain Tumors.Asian Pac J Cancer Prev. 2013;14(7):4101-6 PMID:23991960
  7. Toptaş B, Kurt O, Aydoğan HY, Yaylim I, Zeybek U, Can A, Agachan B, Uyar M, Ozyavuz MK, Isbir T. Investigation of the common paraoxonase 1 variants with paraoxonase activity on bone fragility in Turkish patients.Mol Biol Rep. 2013 Sep 23. PMID: 24057271
  8. Dalan ABTimirci-Kahraman OTuran SKafadar AMYaylim IErgen AGormus UGulec-Yilmaz SKaspar CIsbir T. Association between FAS and FASL Genetic Variants and Risk of Primary Brain Tumor. Int J Neurosci.2013 Oct 7.
  9. Yilmaz U, Zeybek U, Kahraman OT, Kafadar AM, Toptas B, Yamak N, Celik F, Yaylim I. Investigation of ICAM-1 and β3 Integrin Gene Variations in Patients with Brain Tumors.Asian Pac J Cancer Prev. 2013;14(10):5929-34. PMID:24289603
  10. Nazlı Ezgi Ozkan , Ilhan Yaylim. Endothelial Nitric Oxide Synthase Genetic Polymorphisms and Their Potential Involvement in Cancer. Journal of Rashid Latif Medical College 2 (2013) 01-07
  11. Kanliada D, Coskunpinar E, Orhan KS, Oltulu YM, Celik M, Eren A, Yaylim I, Deger K. Investigation of Biomarker in Laryngeal Carcinomas.J Clin Lab Anal. 2014 Jan 6. doi: 10.1002/jcla.21664. PMID:24395286.
  12. Canbay EKahraman OTBugra DCaykara BSeyhan MFBulut TYamaner SOzturk O. Association between PTEN IVS4 polymorphism and development of colorectal cancer in a Turkish population. Expert Opin Ther Targets.2013 Jan;17(1):1-6. doi: 10.1517/14728222.2013.727398. Epub 2012 Oct 14..
  13. Ozturk O, Canbay E, Kahraman OT, Fatih Seyhan M, Aydogan F, Celik V, Uras C. HER2 Ile655Val and PTEN IVS4 polymorphisms in patients with breast cancer. Mol Biol Rep. 2013 Feb;40(2):1813-8. (Impact factor: 2,506)
  14. Dağlar-Aday AToptaş BOztürk TSeyhan FSaygılı NEronat APAkadam-Teker BYılmaz-Aydoğan HAksoy FOztürk O.Investigation of BRAF V600E Mutation in Papillary Thyroid Carcinoma and Tumor-Surrounding Nontumoral Tissues.  DNA Cell Biol.2013 Jan;32(1):13-8. doi: 10.1089/dna.2012.1776. Epub 2012 Nov 16.
  15. Canbay EKahraman OTBugra DCaykara BSeyhan MFBulut TYamaner SOzturk O. Increased gastric cancer risk with PTEN IVS4 polymorphism in a Turkish population. Genet Test Mol Biomarkers.2013 Mar;17(3):249-53. doi: 10.1089/gtmb.2012.0306. Epub 2013 Feb 12.
  16. Yilmaz-Aydogan HKurnaz OKucukhuseyin OAkadam-Teker BKurt OEronat APTekeli ABugra ZOzturk O. Different effects of PPARA, PPARG and ApoE SNPs on serum lipids in patients with coronary heart disease based on the presence of diabetes. 2013 Jul 1;523(1):20-6. doi: 10.1016/j.gene.2013.03.136. Epub 2013 Apr 11.
  17. Akadam-Teker B, Kurnaz O, Coskunpinar E, Daglar-Aday A, Kucukhuseyin O, Cakmak HA, Teker E, Bugra Z, Ozturk O, Yilmaz-Aydogan H. The effects of age and gender on the relationship between HMGCR promoter-911 SNP (rs33761740) and serum lipids in patients with coronary heart disease.  Gene. 2013 Aug 8. doi:pii: S0378-1119(13)00964-5. 10.1016/j.gene.2013.07.056
  18. Kucukhuseyin OKurnaz OAkadam-Teker ABIsbir TBugra ZOzturk OYilmaz-Aydogan H. The Association of MTHFR C677T Gene Variants and Lipid Profiles or Body Mass Index in Patients With Diabetic and Nondiabetic Coronary Heart Disease. J Clin Lab Anal. 2013 Nov;27(6):427-34. doi: 10.1002/jcla.21623
  19. Dalan AB, Toptaş B, Buğra Z, Polat N, Yılmaz-Aydoğan H, Çimen A, Isbir T. The effects of endothelial lipase gene (LIPG) variants on inflammation marker levels and atherosclerosis development. Mol Biol Rep. 2013;40(8):5143-9.
  20. Hülya Yılmaz Aydoğan, Özlem Kurt, Özlem Kurnaz, Başak Akadam Teker, Özlem Küçükhüseyin Koroner kalp hastalığında peroksizom proliferatör-aktive reseptör (PPAR) izoformları [Peroxisome proliferator-activated receptor (PPAR) isoforms in coronary heart disease]. Türk Biyokimya Dergisi [Turkish Journal of Biochemistry–Turk J Biochem] 2013; 38 (4) ; 372–384
  21. Kozanoglu I, Yandim MK, Cincin ZB, Ozdogu H, Cakmakoglu B, Baran Y. New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myeloma. J Cancer Res Clin Oncol. 2013 Feb;139(2):327-35     impact factor: 2.91
  22. Gokkusu C, Cakmakoglu B, Dasdemir S, Tulubas F, Elitok A, Tamer S, Seckin S, Umman B. Association Between Genetic Variants of DNA Repair Genes and Coronary Artery Disease. Genet Test Mol Biomarkers. 2013 Apr;17(4):307-13. impact factor: 1.444
  23. Dasdemir S, Cetinkaya Y, Gencer M, Ozkok E, Aydin M, Cakmakoglu B. Cox-2 gene variants in migraine. Gene. 2013 Apr 15;518(2):292-5. 2.196   impact factor:2.196
  24. Haytural H, Yalcinkaya N, Akan G, Arikan S, Ozkok E, Cakmakoglu B, Yaylim I,Aydin M, Atalar F. Identification of a Novel BRCA2 and CHEK2 A-C-G-C Haplotype in Turkish Patients Affected with Breast Cancer. Asian Pac J Cancer Prev.2013;14(5):3229-35.   impact factor: 1.271
  25. Toptaş B, Kurt O, Aydoğan HY, Yaylim I, Zeybek U, Can A, Agachan B, Uyar M,Ozyavuz MK, Isbir T. Investigation of the common paraoxonase 1 variants with paraoxonase activity on bone fragility in Turkish patients. Mol Biol Rep. 2013 Nov;40(11):6519-24.   impact factor:2.506
  26. Metin ZB, Aydin S, Unur M, Cakmakoglu B, Toptas B, Hafiz G, Isbir T. Oral squamous cell carcinoma and serum paraoxonase 1. J Laryngol Otol. (2013), 127, 1208–1213     impact factor:0.681
  27. Tanyel C.R., Cincin Z.B., Gokcen-Rohlig B., Bektas-Kayhan K., Unur M. and Cakmakoglu B.. Effects of genetic variants of CCR5 chemokine receptors on oral squamous cell carcinoma.Genet. Mol. Res. 12 (4): 5714-5720 (2013)   impact factor:0.844
  28. Karatoprak, Ö., Z. Ermiş Karaali, K. İncekara, F. Çelik, Ü. Zeybek, H.A. Ergen, T. Isbir, “Tip 2 diyabette mdr1 gen polimorfizmlerinin rolü”, Turk J Biochem, 38(2): 186-192, (2013). (IF:0,211)
  29. Atasever Arslan, B., S. Erdem-Kuruca, Z. Karakas, B. Erman, A. Ergen. “Effects of micro environmental factors on natural killer activity (NK) of Beta Thalassemia major patients”, Cell Immunol, 282(2):93-9, (2013). (IF:1,743)
  30. Eksi, YE., Z. Ermis Karaali, K. Incekara, H. A. Ergen, “Myeloperoxidase And Glutamate-Cysteine Ligase Polymorphisms In Type 2 Diabetes Mellitus: A Preliminary Study”, J Med Biochem 32: 1–6, (2013).(IF:1,084)
  31. Gormus U, Timirci-Kahraman O, Ergen A, Kunt AT, Isbir S, Dalan AB, Isbir T. Expression Levels of Elastin and Related Genes in Human Varicose Veins. Folia Biologica. (Kabul Edildi). (Impact factor: 0,889)
  32. Gormus U, Kahraman OT, Toptas B, Isbir T, Ciftci Cavlan, Berkkan HH, Dalan AB, Karatay MC. Leptin (LEP) and Leptin Receptor (LEPR) Polymorphisms are related to Body Mass Index (BMI) in Turkish Population. TUBITAK-Turkish Medical of Sciences. (Kabul Edildi). (Impact factor: 0,450)

 

2012

  1. Yaylim I, Ozkan NE, Turan S, Korkmaz G, Yildiz Y, Cacina C, Topbas B, Arikan S. sTRAIL Serum Levels and TRAIL 1595 Genotypes: Association with Progress and Prognosis of Colorectal Carcinoma. Journal of Cancer Therapy 2012 3:941-947.
  2. Yaylim I, Ozkan NE, Isitmangil T, Isitmangil G, Turna A, Isbir T. CK2 Enzyme Affinity Against c-myc424-434 Substrate in Human Lung Cancer Tissue.Asian Pac J Cancer Prev. 2012;13(10):5233-6.
  3. Yılmaz-Aydogan H, Kucukhuseyin O, Kurnaz O, Akadam-Teker B, Kurt O, Tekeli A, Ozturk O, Isbir T. Investigation of polymorphic variants of PPARD and APOE genes in Turkish coronary heart disease patients. DNA Cell Biol. 2012 May;31(5):867-75. doi: 10.1089/dna.2011.1464. Epub 2012 Jan 25.
  4. Dağlar-Aday A, Toptaş B, Oztürk T, Seyhan F, Saygılı N, Eronat AP, Akadam-Teker B, Yılmaz-Aydoğan H, Aksoy F, Oztürk O. Investigation of BRAF V600E Mutation in Papillary Thyroid Carcinoma and Tumor-Surrounding Nontumoral Tissues.  DNA Cell Biol. 2013 Jan;32(1):13-8. doi: 10.1089/dna.2012.1776. Epub 2012 Nov 16.
  5. Ergen HA, Zeybek Ü, Gök Ö, Ermis Karaali Z. Investigation Of ABCA1 C69T Polymorphism In Patients With Diabetes Mellitus Type 2. Biochemia Medica 2012;22(1):114–20. (Impact Factor: 1,343)
  6. Turna A, Pekçolaklar A, Metin M, Yaylim I, Gurses A. The effect of season of operation on thesurvival of patients with resected non-small cell lung cancer.InteractCardiovascThoracSurg. 2012 Feb;14(2):151-5.
  7. Bektas-Kayhan K, Kucukhuseyin O, Karagoz G, Unur M, Ozturk O, Unuvar A, Devecioglu O, Yilmaz-Aydogan H. Is the MDR1 C3435T Polymorphism Responsible for Oral Mucositis in Children with Acute Lymphoblastic Leukemia? Asian Pac J Cancer Prev. 2012;13(10):5251-5.
  8. Ö. Gül, E. Öztürk, M G Uğur, F B Cebesoy, N Kurtul, S Pençe, S Pehlivan, Ö Balat.Preeklamptik Gebelerde Serum Total Sialik Asit Seviyeleri ve Sialik Asit Esteraz Gen Varyasyonu. J Turk Soc Obstet Gynecol. 9(2),99-105. (2012).
  9. Colak Y, Senates E, Yesil A, Yilmaz Y, Ozturk O, Doganay L, Coskunpinar E, Kahraman OT, Mesci B, Ulasoglu C, Tuncer I. Assessment of endothelial function in patients with nonalcoholic fatty liver disease. Endocrine. 2012 Jun 3. [Epub ahead of print] PMID:22661277  (Impact factor; 1,416)
  10. Senateş E, Colak Y, Yeşil A, Coşkunpinar E, Sahin O, Kahraman OT, Erkalma Şenateş B, Tuncer I. Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance and nonalcoholic steatohepatitis scores. Minerva Med. 2012 Oct;103(5):369-76.
  11. Canbay E, Kurnaz O, Canbay B, Bugra D, Cakmakoglu B, Bulut T, Yamaner S, Sokucu N, Buyukuncu Y, Yilmaz-Aydogan H. PPAR-Gamma Pro12Ala Polymorphism and Gastric Cancer Risk in a Turkish Population. Asian Pac J Cancer Prev. 2012;13(11):5875-8.
  12. Gündüz M, Cacına C, Toptaş B, Yaylım-Eraltan I, Tekand Y, Isbir T. Association of vitamin d receptor gene polymorphisms with colon cancer. Genet Test Mol Biomarkers. 2012 Sep;16(9):1058-61. Epub 2012 Aug 1
  13. Dağlar-Aday A, Toptaş B, Oztürk T, Seyhan F, Saygılı N, Eronat AP, Akadam-Teker B, Yılmaz-Aydoğan H, Aksoy F, Oztürk O. Investigation of BRAF V600E Mutation in Papillary Thyroid Carcinoma and Tumor-Surrounding Nontumoral Tissues. DNA Cell Biol. 2013 Jan;32(1):13-8. doi: 10.1089/dna.2012.1776. Epub 2012 Nov 16.
  14. Kucukhuseyin O, Yilmaz-Aydogan H, Isbir CS, Isbir T, “Is there any association between GLY82 ser polymorphism of rage gene and Turkish diabetic and non diabetic patients with coronary artery disease?”, Mol Biol Rep. 2012; 39:4423–4428
  15. Engin Aynaci, Ender Coskunpinar, Ayse Eren, Onur Kum, Yasemin Musteri Oltulu, Nergiz Akkaya, Akif Turna, İlhan Yaylim and Pinar Yildiz. Association between survivin gene promoter -31G/C and -644C/T polymorphisms and non-small cell lung cancer. Genetics and Molecular Research, 2012 (in press)
  16. Ender Coşkunpınar, Sema Anak, Leyla Ağaoğlu, Ayşegül Ünüvar, Ömer Devecioğlu, Gönül Aydoğan, Çetin Timur, Ahmet Faik Öner, Yıldız Yıldırmak, Tiraje Celkan, İnci Yıldız, Nazan Sarper, Uğur Özbek. Analysis of Chromosomal Aberrations and FLT3 gene Mutations in Childhood Acute Myelogenous Leukemia Patients Turk J Hematol 2012; 29 (3) : 225-232 doi: 10.5505/tjh.2012.24392
  17. Engin Aynacı, Ender Coşkunpınar, Ayşe Eren, Onur Kum, Yasemin Müşteri Oltulu, Nergiz Akkaya, Akif Turna, İlhan Yaylım, Pınar Yıldız. Investigation of the association of survivin gene -625G/C polymorphism in non-small cell lung cancer. Journal of Cell and Molecular Biology 2012, 10(1):27-32, Haliç University.
  18. Eraltan H, Cacina C, Kahraman OT, Kurt O, Aydogan HY, Uyar M, Can A, Cakmakoğlu B. MCP-1 and CCR2 gene variants and  the risk for osteoporosis and osteopenia. Genet Test Mol Biomarkers. 2012 Apr;16(4):229-33. Epub 2011 Nov 14. PMID:22081934
  19. Akbas F, Coskunpinar E, Aynacı E, Oltulu YM, Yildiz.P. Analysis of serum miRNAs as potential biomarker in COPD. Exp Lung Res. 2012 2012 Aug;38(6):286-94.
  20. Colak Y, Senates E, Ozturk O, Doganay HL, Coskunpinar E, Oltulu YM, Eren A, Sahin O, Ozkanli S, Enc FY, Ulasoglu C, Tuncer I. Association of serum lipoprotein-associated phospholipase A2 level with nonalcoholic fatty liver disease. Metab Syndr Relat Disord. 2012 Apr;10(2):103-9.
  21. Senateş E, Colak Y, Erdem ED, Yeşil A, Coşkunpınar E, Sahin O, Altunöz ME, Tuncer I, Kurdaş Övünç AO. Serum anti-Müllerian hormone levels are lower in reproductive-age women with Crohn’s disease compared to healthy control women. J Crohns Colitis. 2012 Apr 1. [Epub ahead of print] PubMed PMID: 22472089
  22. Mogulkoc U., Coskunpinar E., Caglar E., Ortaköylü G., Ozkan G., Musteri Oltulu Y., Yaylim-Eraltan I. Is MMP-7 Gene Polymorphism A Possible Risk Factor For Copd In Turkish Patients. Genet Test Mol Biomarkers. 2012 Jun;16(6):519-23. Epub 2012 Mar 14.
  23. Sahin O, Arikan S, Musteri Oltulu Y, Coskunpinar E, Eren A, Cacina C, Guler E, Yaylim I.Investigation of a Possible Relationship Between EPHX1 Gene Polymorphisms and Colorectal Cancer in Turkish Society. Genet Test Mol Biomarkers. 2012 Feb 21. [Epub ahead of print].
  24. Gurdol F, Cakmakoglu B, Dasdemir S, Isbilen E, Bekpinar S, Isbir T. -765 G→C and -1195 A→G Promoter Variants of the Cyclooxygenase-2 Gene Decrease the Risk for Preeclampsia. Genet Test Mol Biomarkers. 2012 Jan 6. [Epub ahead of print] PubMed PMID: 22224631.
  25. Bektas-Kayhan K, Unur M, Boy-Metin Z, Cakmakoglu B. MCP-1 and CCR2 gene variants in oral squamous cell carcinoma. Oral Dis. 2012 Jan;18(1):55-9. doi: 10.1111/j.1601-0825.2011.01843.x. Epub 2011 Aug 24. PMID:21883707
  26. Inal Gultekin G, Raj K, Lehman S, Hillström A, Giger U. Missense mutation in PFKM associated with muscle-type phosphofructokinase deficiency in the Wachtelhund dog. Mol Cell Probes. 2012 Mar 16. [Epub ahead of print]  PMID:22446493  İmpact Factor: 2,078.
  27. Inal Gultekin G, Raj K, Foureman P, Lehman S, Manhart K, Abdulmalik O, Giger U. Erythrocytic Pyruvate Kinase Mutations Causing Hemolytic Anemia, Osteosclerosis, and Secondary Hemochromatosis in Dogs. J Vet Intern Med. 2012 Jul 13. doi: 10.1111/j.1939-1676.2012.00958.x. [Epub ahead of print]  PMID:22805166  İmpact Factor: 1.992.
  28. Kurt O, Yilmaz-Aydogan H, Uyar M, Isbir T, Seyhan MF, Can A. Evaluation of ERa and VDR gene polymorphisms in relation to bone mineral density in Turkish postmenopausal women.  Mol Biol Rep. 2012 Jun;39(6):6723-30. Epub 2012 Feb 7.
  29. Yılmaz-Aydogan H, Kucukhuseyin O, Kurnaz O, Akadam-Teker B, Kurt O, Tekeli A, Ozturk O, Isbir T. Investigation of Polymorphic Variants of PPARD and APOE Genes in Turkish Coronary Heart Disease Patients.  DNA Cell Biol. 2012 May;31(5):867-75. Epub 2012 Jan 25. PMID:22277050
  30. Aydoğan HY, Küçükhüseyin O, Tekeli A, Isbir T. Associations of Receptor For Advanced Glycation End Products (RAGE) -374 T/ A and Gly82 Ser and Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) Pro12Ala Polymorphisms In Turkish Coronary Artery Disease Patients. Genet Test Mol Biomarkers. 2012 Feb;16(2):134-7. Epub 2011 Aug 23. PMID:21861709
  31. Yildiz I, Unuvar E, Zeybek U, Toptas B, Toprak SK, Cacina C, Kilic A, Aydin S. The role of vitamin D in children with recurrent Tonsillopharyngitis. Ital J Pediatr. 2012 Jun 8;38(1):25. [Epub ahead of print]. PMID:22682426  İmpact Factor:
  32. Baş F, Darendeliler F, Aycan Z, Cetinkaya E, Berberoğlu M, Sıklar Z, Ocal G, Timirci O, Cetinkaya S, Darcan S, Gökşen Şimşek D, Bideci A, Cinaz P, Böber E, Demir K, Bereket A, Turan S, Atabek ME, Tütüncüler F, Isbir T, Bozkurt N, Kabataş Eryılmaz S, Uzunhan O, Küçükemre Aydın B, Bundak R. The exon 3-deleted/full-length growth hormone receptor polymorphism and response to growth hormone therapy in growth hormone deficiency and turner syndrome: a multicenter study. Horm Res Paediatr. 2012;77(2):85-93. Epub 2012 Mar 23. PMID:22456308  (Impact factor; 2,48)
  33. Colak Y, Senates E, Yesil A, Yilmaz Y, Ozturk O, Doganay L, Coskunpinar E, Kahraman OT, Mesci B, Ulasoglu C, Tuncer I. Assessment of endothelial function in patients with nonalcoholic fatty liver disease. Endocrine. 2012 Jun 3. [Epub ahead of print] PMID:22661277  (Impact factor; 1,416)
  34. Ergen HA, Zeybek Ü, Gök Ö, Ermis Karaali Z. Investigation Of ABCA1 C69T Polymorphism In Patients With Diabetes Mellitus Type 2. Biochem Med (Zagreb). 2012;22(1):114-20. PMID:22384526
  35. Canbay E, Ergen A, Bugra D, Yamaner S, Eraltan IY, Buyukuncu Y, Bulut T. Kisspeptin-54 Levels are increased in Patients with Colorectal Cancer. World J Surg. 2012 May 3. [Epub ahead of print] PMID:22552499
  36. Eren Z, Kantarci G, Biyikli N, Arikan H, Tuglular S, Ergen A, Isbir T, Akoglu E.  Paraoxonase 1 polymorphisms in patients with primary glomerulonephritis: a single-center study in Turkey. Iran J Kidney Dis. 2012 May;6(3):181-5. PMID:22555481
  37. Tükel R, Arslan BA, Ertekin BA, Ertekin E, Oflaz S, Ergen A, Kuruca SE, Isbir T. Decreased IFN-γ and IL-12 levels in panic disorder. J Psychosom Res. 2012 Jul;73(1):63-7. Epub 2012 May 20. PMID: 22691562
  38. Cincin ZB, Iyibozkurt AC, Kuran SB, Cakmakoglu B. DNA repair gene variants in endometrial carcinoma. Med Oncol. 2012 Jan 22. [Epub ahead of print]  PMID:22271435
  39. Gurdol F, Yurdum LM, Ozturk U, Isbilen E, Cakmakoglu B. Association of the CC chemokine receptor 5 (CCR5) polymorphisms with preeclampsia in Turkish women. Arch Gynecol Obstet. 2012 Feb 5. [Epub ahead of print] PMID: 22314435
  40. Eraltan H, Cacina C, Timirci Kahraman O, Kurt O, Yilmaz Aydogan H, Uyar M, Can A, Cakmakoğlu B. MCP-1 and CCR-2 gene variants and the risk for osteoporosis and osteopenia. Genet Test Mol Biomarkers. 2012 Apr;16(4):229-33. 2012 Apr;16(4):229-33. Epub 2011 Nov 14. PMID: 22081934
  41. Kucukgergin C, Isman FK, Cakmakoglu B, Sanli O, Seckin S. Association of Polymorphisms in MCP-1, CCR2, and CCR5 Genes with the Risk and Clinicopathological Characteristics of Prostate Cancer. DNA Cell Biol. 2012 May 21. [Epub ahead of print] PubMed PMID: 22612293.
  42. Gencer M, Dasdemir S, Cakmakoglu B, CetinkayaY, Varlibas F, Tireli H, Kucukali CI, Ozkok E, Aydin M. DNA repair genes in parkinson’s disease. Genet Test Mol Biomarkers. 2012 Jun;16(6):504-7.  Epub 2012 Jan 6. PMID: 22224629
  43. Kurnaz O, Akadam-Teker A.B, Yilmaz- Aydogan H, Tekeli A, İsbir  T. LOX-1 3’UTR188CT Polymorphism and coronary artery disease in Turkish patients .Mol Biol Rep. 2012 Apr;39(4):4351-8.  Epub 2011 Sep 7. PMID:21901421
  44. Arıkan S, Cacina C, Guler E, Çulcu S, Tuna G, Yaylım-Eraltan I. The effects of NOS3 Glu298Asp variant on colorectal cancer risk and progression in Turkish population. . Mol Biol Rep. 2012 Mar;39(3):3245-9. doi: 10.1007/s11033-011-1092-8.

 

2011

  1. Acilmis YG, Dikensoy E, Kutlar AI, Balat O, Cebesoy FB, Ozturk E, Cicek H, Pence S. Homocysteine, folic acid and vitamin b12 levels in maternal and umbilical cord plasma and homocysteine levels in placenta in pregnant women with preeclampsia. J Obstet Gynaecol Res. 2011 Jan;37(1):45-50. doi: 10.1111/j.1447-0756.2010.01317.x. Epub 2010 Oct 11. PMID:21040211
  2. Ozturk E, Balat O, Ugur M, Yazicioglu C,  Pence s, Erel  O, Kul S.   Effect of ramadan fastıng on maternal oxidatıve stress during the second trimester: a preliminary study. The J of Obstet. Gynaecol. Res. 2011 Jul;37(7):729-33
  3. Ozturk E, Balat O, Acılmıs Y, Ozcan C, Pence S, Erel  O. Measurement of the placental total antıoxıdant status in preeclamptic women using a novel automated   method. J Obstet Gynaecol Res. 2011 Jul;37(7):729-33. doi: 10.1111/j.1447-0756.2010.01419.x. Epub 2011 Mar 9. PMID:21736666
  4. Atik  B, Erkutlu I,Tercan M, Buyukhatipoglu M, Bekerecioglu M, Pence S. The effects of exogenous melatonin on peripheral nerve regeneration and collagen formation in rats. J Surg Res. 2011 Apr;166(2):330-6. Epub 2009 Jul 10. PMID: 20006352
  5. Küçükhüseyin Ö, Kurnaz Ö, Akadam-Teker AB, Narter F, Yılmaz-Aydoğan H, İsbir T. Effects of the MTHFR C677T Polymorphism on Prostate Specific Antigen and Prostate Cancer. Asian Pac J Cancer Prev. 2011;12(9):2275-8. PMID:22296369
  6. Yilmaz-Aydogan H, Kurnaz O, Kurt O, Akadam-Teker B, Kucukhuseyin O, Tekeli A, Isbir T. Effects of the PPARG P12A and C161T Gene Variants on Serum Lipids in Coronary Heart Disease Patients with and without Type 2 Diabetes. Mol Cell Biochem. 2011 Dec;358(1-2):355-63. Epub 2011 Jul 21. PMID: 21833536
  7. Kucukhuseyin O, Yilmaz-Aydogan H, Isbir CS, Isbir T. Is there any association   between GLY82 ser polymorphism of rage gene and Turkish diabetic and non diabetic patients with coronary artery disease? Mol Biol Rep. 2012 Apr;39(4):4423-8.  Epub 2011 Sep 25. PMID:21947881
  8. Kurt  Ozlem, Aydogan Hulya Yilmaz, Uyar  Mehmet, Seyhan  Mehmet Fatih, Isbir  Turgay,  Can  Ayse. Association Between Collagen Type I [A](1) (Col1a1) Gene Polymorphism Wıth Bone Mineral Density In Turkish Postmenopausal Women. Osteoporosıs Int. 2011;22(1);180-181.
  9. Arıkan S, Cacina C, Guler E, Culcu S, Tuna G, Yaylım-Eraltan I. The effects ofNOS3 Glu298Asp variant on colorectal cancer risk and progression in Turkish population. Mol Biol Rep. 2012 Mar;39(3):3245-9. Epub 2011 Jun 25. PubMed PMID: 21706163.
  10. Cacina C, Bulgurcuoglu-Kuran S, Iyibozkurt AC, Yaylim-Eraltan I, Cakmakoglu B. Genetic variants of SDF-1 and CXCR4 genes in endometrial carcinoma. Mol Biol Rep. 2012;39(2):1225-9. Epub 2011 May 24. PMID:21607621
  11. Turna A, Pekçolaklar A, Metin M, Yaylim I, Gurses A. The effect of season of operation on the survival of patients with resected non-small cell lung cancer. Interact Cardiovasc Thorac Surg. 2012 Feb;14(2):151-5. Epub 2011 Nov 30. PMID: 22159250
  12. Isbir O, Gormuş U, Ergen HA, Cakmakoğlu B, Kahraman OT, Baykan N. XPD and hOGG1 gene polymorphisms in reperfusion oxidative stress. Genet Mol Res. 2011 Dec 19;10(4):3157-62. PMID:22194171
  13. Agachan Cakmakoglu B, Attar R, Kahraman OT, Dalan AB, Iyibozkurt AC, Karateke A, Attar E. Cyclooxygenase-2 gene and epithelial ovarian carcinoma risk. Mol Biol Rep. 2011 Jun;38(5):3481-6. Epub 2010 Nov 24. PMID: 21107726
  14. Coskunpinar E, Eraltan IY, Turna A, Agachan B. Cyclooxygenase-2 gene and lung carcinoma risk. Med Oncol. 2011 Dec;28(4):1436-40. Epub 2010 Jul 20. PMID:20645029
  15. Colak Y, Senates E, Ozturk O, Yilmaz Y, Coskunpinar E, Kahraman OT, Sahin O, Zemheri E, Enc FY, Ulasoglu C, Kiziltas S, Kurdas OO, Tuncer I. Plasma Fibrinogen-Like Protein 2 Levels in Patients with Non-Alcoholic Fatty Liver Disease. Hepatogastroenterology. 2011 Nov-Dec;58(112):2087-90. doi: 10.5754/hge11248. PMID:22024080
  16. Aydın S, Aslan I, Yıldız I, Ağaçhan B, Toptaş B, Toprak S, Değer K, Oktay MF, Unüvar E. Vitamin D levels in children with recurrent tonsillitis. Int J Pediatr Otorhinolaryngol. 2011 Mar;75(3):364-7. Epub 2011 Jan 7. PMID:21215466
  17. Canbay E, Cakmakoglu B, Zeybek U, Sozen S, Cacina C, Gulluoglu M, Balik E,Bulut T, Yamaner S, Bugra D. Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population. Curr Med Res Opin. 2011 Jul;27(7):1295-302. Epub 2011 May 12. PMID:21561390
  18. Zeybek U, Toptas B, Karaali ZE, Kendir M, Cakmakoglu B. Effect of TNF-α and IL-1β genetic variants on the development of myocardial infarction in Turkish population. Mol Biol Rep. 2011 Nov;38(8):5453-7. Epub 2011 Mar 6. PMID:21380730
  19. Baş F, Keleşoğlu F, Timirci Ö, Kabataş Eryılmaz S, Bozkurt N, Küçükemre Aydın B, Bundak R, Isbir T, Darendeliler F. The distribution of exon 3-deleted/full-length growth hormone receptor polymorphism in the Turkish population. J Clin Res Pediatr Endocrinol. 2011;3(3):126-31. doi: 10.4274/jcrpe.v3i3.25. PMID: 21911325
  20. Aydoğan HY, Küçükhüseyin O, Tekeli A, Isbir T. Associations of Receptor for Advanced Glycation End Products -374 T/A and Gly82 Ser and Peroxisome Proliferator-Activated Receptor Gamma Pro12Ala Polymorphisms in Turkish Coronary  Artery Disease Patients. Genet Test Mol Biomarkers. 2012 Feb;16(2):134-7. Epub 2011 Aug 23. PMID: 21861709
  21. Aksoy-Sagirli P, Cakmakoglu B, Isbir T, Kaytan-Saglam E, Kizir A, Topuz E,Berkkan H. Paraoxonase-1 192/55 polymorphisms and the risk of lung cancer in a Turkish population. Anticancer Res. 2011 Jun;31(6):2225-9. PMID: 21737645
  22. Ozturk T, Kahraman OT, Toptaş B, Kisakesen HI, Çakalir C, Verim L, Ozturk O, Isbir T. The effect of CYP1A1 and GSTM1 gene polymorphisms in bladder cancer development in a Turkish population. In Vivo. 2011 Jul-Aug;25(4):663-8. PMID:21709011
  23. Toptas B, Gormuş U, Ergen A, Gurkan H, Kelesoglu F, Darendeliler F, Bas F, Dalan AB, Izbirak G, Isbir T. Comparison of lipid profiles with APOA1 MspI polymorphism in obese children with hyperlipidemia. In Vivo. 2011 May-Jun;25(3):425-30. PMID:21576418
  24. Gormuş U, Kahraman OT, Isbir S, Tekeli A, Isbir T. MMP2 gene polymorphisms and MMP2 mRNA levels in patients with superficial varices of lower extremities. In Vivo. 2011 May-Jun;25(3):387-91. PMID:21576412
  25. Ol KK, Agachan B, Gormus U, Toptas B, Isbir T. Cox-2 gene polymorphism and IL-6 levels in coronary artery disease. Genet Mol Res. 2011 May 10;10(2):810-6. PMID:21574137
  26. Narter F, Can G, Ergen A, Isbir T, Ince Z, Çoban A. Neonatal hyperbilirubinemia and G71R mutation of the UGT1A1 gene in Turkish patients. J Matern Fetal Neonatal Med. 2011 Feb;24(2):313-6. Epub 2010 Jun 8. PMID:20528217
  27. Ergul Ekiz, E., Arslan, M., Ozcan, M., Inal Gültekin, G., Yildiz Gulay, O. Kirmizibayrak, T., Giger. U. Frequency of dog erythrocyte antigen 1.1 in 4 breeds native to different areas in Turkey.Vet Clin Pathol. 2011 Dec;40(4):518-23. doi: 10.1111/j.1939-165X.2011.00370.x. PMID:22136478
  28. Emre S, Sirin A, Ergen A, Bilge I, Sucu A, Yilmaz A, Isbir T. Methylenetetrahydrofolate Reductase C677T Polymorphism In Patients With Henoch-Schönlein Purpura. Pediatr Int. 2011 Jun;53(3):358-62. doi: 10.1111/j.1442-200X.2010.03247.x. PMID:20831652
  29. Matur, E., Ergül, E., Akyazı, I., Eraslan, E., Inal Gultekin, G., Bilgiç, S., Demircan, H.: Effects of Saccharomyces cerevisiae extract on haematological parameters, immune function and the antioxidant defence system in breeder hens fed aflatoxin contaminated diets.Br Poult Sci. 2011 Oct;52(5):541-50. PMID:22029780
  30. Yarat A, Ozturk LK, Ulucan K, Akyuz S, Atala H, Isbir T. Carbonic anhydrase VI exon 2 genetic polymorphism in Turkish subjects with low caries experience (preliminary study). In Vivo. 2011 Nov Dec;25(6):941-4. PubMed PMID: 22021688.
  31. Ergen A, İsbir S, Timirci O, Tekeli A, Isbir T. Effects of myeloperoxidase -463 G/A gene polymorphism and plasma levels on coronary artery disease. Mol Biol Rep. 2011 Feb;38(2):887-91. Epub 2010 Jun 22. PMID:20568015
  32. Tetik S, Ak K, Sahin Y, Gulsoy O, Isbir S, Arsan S, Yardimci T. Postoperative statin therapy attenuates the intensity of systemic inflammation and increases fibrinolysis after coronary artery bypass grafting. Clin Appl Thromb Hemost. 2011 Oct;17(5):526-31. Epub 2010 Aug 30. PubMed PMID: 20805103.
  33. Acilmis YG, Dikensoy E, Kutlar AI, Balat O, Cebesoy FB, Ozturk E, Cicek H, Pence S.Homocysteine, folic acid and vitamin B12 levels in maternal and umbilical cord plasma and homocysteine levels in placenta in pregnant women with pre‐J Obstet Gynaecol Res. 2011 Jan;37(1):45-50. doi: 10.1111/j.1447-0756.2010.01317.x. Epub 2010 Oct 11.
  34. Ergen A, Kılıcoglu O, Ozger H, Agachan B, Isbir T. Paraoxonase 1 192 and 55 polymorphisms in osteosarcoma. Mol Biol Rep. 2011 Aug;38(6):4181-4. Epub 2010 Nov 23. PMID: 21104436
  35. Ozturk E, Balat O, Acılmıs YG, Ozcan C, Pence S, Erel Ö.Measurement of the placental total antioxidant status in preeclamptic women using a novel automated method.J Obstet Gynaecol Res. 2011 Apr;37(4):337-42. doi: 10.1111/j.1447-0756.2010.01346.x. Epub 2011 Feb 11.
  36. Atik B, Erkutlu I, Tercan M, Buyukhatipoglu H, Bekerecioglu M, Pence S.The effects of exogenous melatonin on peripheral nerve regeneration and collagen formation in rats.J Surg Res. 2011 Apr;166(2):330-6. Epub 2009 Jul 10.

 

2010

  1. Agaçhan B, Küçükhüseyin O, Aksoy P, Turna A, Yaylim I, Görmüs U, Ergen A, Zeybek U, Dalan B, Isbir T. Apurinic/apyrimidinic endonuclease (APE1) gene polymorphisms and lung cancer risk in relation to tobacco smoking.Anticancer Res. Jun;29(6):2417-20. (2009)
  2. Bektas-Kayhan KUnür MYaylim-Eraltan IErgen AHafiz GKaradeniz AIsbir T. Role of L-MYC polymorphism in oral squamous cell carcinoma in Turkey. Anticancer Res. 2009 Jul;29(7):2519-24.
  3. Yaylim-Eraltan IErgen AGörmüs UArikan SKüçücük SSahin OYigit NYildiz YIsbir T. Breast cancer and cyclin D1 gene polymorphism in Turkish women. In Vivo. 2009 Sep-Oct;23(5):767-72.
  4. Kurnaz OAydogan HYIsbir CSTekeli AIsbir T. Is LOX-1 K167N polymorphism protective for coronary artery disease? In Vivo. 2009 Nov-Dec;23(6):969-73.
  5. Kucukhuseyin OAydogan HYIsbir CSIsbir T. Associations of -374T/A polymorphism of receptor for advanced glycation end products (RAGE) gene in Turkish diabetic and non-diabetic patients with coronary artery disease. In Vivo. 2009 Nov-Dec;23(6):949-54.
  6. Yilmaz AEmre SAgachan BBilge IYilmaz HErgen AIsbir TSirin A. Effect of paraoxonase 1 gene polymorphisms on clinical course of Henoch-Schönlein purpura. J Nephrol. 2009 Nov-Dec;22(6):726-32.
  7. Timirci ODarendeliler FBas F, Ergen HA, Umit ZIsbir T. Comparison of lipid profiles in relation to APOB EcoRI polymorphism in obese children with hyperlipidemia. In Vivo. 2010 Jan-Feb;24(1):65-9
  8. Cacina C, Yaylim-Eraltan I, Arikan S, Saglam EK, Zeybek U, Isbir T . Association between CDKN1A Ser31Arg and C20T gene polymorphisms and colorectal cancer risk and prognosis.In Vivo. 2010 Mar-Apr;24(2):179-83.
  9. R., B. Agachan, O. Kuçukhuseyin, B. Toptas, E. Attar, T.Isbir. “Association of interleukin 1beta gene (+3953) polymorphism and severity of endometriosis in Turkish women.” Mol Biol Rep. 37, 369-74 (2010).
  10. Narter FCan GErgen AIsbir TInce ZCoban A.Neonatal hyperbilirubinemia and G71R mutation of the UGT1A1 gene in Turkish patients. J Matern Fetal Neonatal Med. 2010 Jun 8.
  11. R., C. Cacina, S. Sozen, E. Attar, B.Agachan. “DNA repair genes in endometriosis.” Genet. Mol. Res. 9: 629-636 (2010).
  12. Attar R, B.Agachan, S.B. Kuran, C. Cacina, S. Sozen, L.M. Yurdum, E. Attar, T.Isbir  “Association Of CCL2 and CCR2 Gene Variants With Endometrial Cancer In Turkish Women.” In Vivo. 24, 243-8 (2010).
  13. K.F.,  B.Agachan., S. Sozen, Z.B. Cincin, T.Isbir. “CCR2-64I is a risk factor for development of bladder cancer.”  Genet Mol Res 9, 685-692 (2010).
  14. R., B.Agachan, S.B. Kuran, B. Toptas, I.Y. Eraltan, E. Attar, T.Isbir. “Genetic variants of vascular endothelial growth factor and risk for the development of endometriosis.” In Vivo. 24(3),297-301 (2010).
  15. E., B.Agachan, M. Gulluoglu, T.Isbir, E. Balik, S. Yamaner, T. Bulut, C. Cacina, I.Y. Eraltan, A. Yilmaz, D. Bugra. “Possible associations of APE1 polymorphism with susceptibility and HOGG1 polymorphism with prognosis in gastric cancer.” Anticancer Res. 30(4),1359-64 (2010).
  16. Z.E., S. Sozen, M. Yurdum, C. Cacina, B. Toptas, O. Gok, B. Agachan. “Effect of genetic variants of chemokine receptors on the development of myocardialinfarction in Turkish population.” Mol Biol Rep.  (basımda).
  17. ”The Influence of Cyclin D1 A870G Polymorphism on Colorectal Cancer Risk and Prognosis in a Turkish Population” (Basımda)
  18. Canbay E, Agachan B, Ozturk T, Giris M, Asoglu O, Balik E, Bugra D. “Dual inhibition of wound healing and oxidative process by Montelukast in experimental colon anastomoses” Surgical Innovation, 17:xxx-xxx, 2010. (yayım için kabul edildi)
  19. Oztürk.O., O.F. Kağnici, T. Öztürk, H. Durak, B.M. Tüzüner, H.I. Kisakesen, C. Cakalır ve T. Isbir. “192R allele of paraoxanase 1 (PON1) gene as a new marker for susceptibility to bladder cancer: ” Anticancer Res.29(10),4041-6 (2009)
  20. Tüzüner.B.M., T. Öztürk, H.I. Kisakesen, S. İlvan, Z Calay, O. Öztürk ve T. Isbir. “CYP17 (T-34C), CYP19 (Trp39Arg) Polymorphisms and their Cooperative Affects on Breast Cancer Susceptibility:” In Vivo.24(1),71-4 (2010)
  21. Ergen AIsbir STimirci OTekeli AIsbir T.Effects of myeloperoxidase -463 G/A gene polymorphism and plasma levels on coronary artery disease. Mol Biol Rep. 2010 Jun 22.
  22. Coskunpinar E, Eraltan IY, Turna A, Agachan B. Cyclooxygenase-2 gene and lung carcinoma risk.Medical Oncology 2010. DOI:10.1007/s12032-010-9627-8( basımda)
  23. Ağachan B, Attar R, Isbilen E, Aydogan  YH, Sozen S, Gürdöl F, Isbir T. Association of MCP-1 and CCR2 Gene Variants with Preeclampsia.Journal of Interferon & Cytokine Research. 2010 ( basımda)
  24. Yasemin K. Ozbek, Tulin Ozturk, Bora M. Tuzuner, Zerrin Calay, Sennur Ilvan, Fatih M. Seyhan, Halil I. Kisakesen, Oguz Ozturk, Turgay İsbir. Combined Effect of CYP1B1 Codon 432 Polymorphism and N-Acetyltransferase 2 Slow Acetylator phenotypes in Relation to Breast Cancer in the Turkish Population. Anticancer Res. (Basımda)

 

2009

  1. Oztürk O, Kağnici OF, Oztürk T, Durak H, Tüzüner BM, Kisakesen HI, Cakalir C,
  2. Isbir T. 192R allele of paraoxanase 1 (PON1) gene as a new marker for susceptibility to bladder cancer. Anticancer Res. 2009 Oct;29(10):4041-6.
  3. Yaylim-Eraltan I, Ergen A, Görmüs U, Arikan S, Küçücük S, Sahin O, Yigit N, Yildiz Y, Isbir T. Breast cancer and cyclin D1 gene polymorphism in Turkish women. In Vivo. 2009 Sep-Oct;23(5):767-72.
  4. Attar R, Agachan B, Kucukhuseyin O, Toptas B, Attar E, Isbir T. Association of interleukin 1beta gene (+3953) polymorphism and severity of endometriosis in Turkish women. Mol Biol Rep. 2009 Sep 13.
  5. Bektas-Kayhan K, Unür M, Yaylim-Eraltan I, Ergen A, Hafiz G, Karadeniz A, Isbir T. Role of L-MYC polymorphism in oral squamous cell carcinoma in Turkey. Anticancer Res. 2009 Jul;29(7):2519-24.
  6. Agaçhan B, Küçükhüseyin O, Aksoy P, Turna A, Yaylim I, Görmüs U, Ergen A, Zeybek U, Dalan B, Isbir T. Apurinic/apyrimidinic endonuclease (APE1) gene polymorphisms and lung cancer risk in relation to tobacco smoking. Anticancer Res. 2009 Jun;29(6):2417-20.
  7. Arpaci A, Görmüs U, Dalan B, Berkman S, Isbir T. Investigation of PON1 192 and PON1 55 polymorphisms in ovarian cancer patients in Turkish population. In Vivo.  2009 May-Jun;23(3):421-4.
  8. Isbilen E, Yilmaz H, Arzu Ergen H, Unlucerci Y, Isbir T, Gurdol F. Association of paraoxonase 55 and 192 gene polymorphisms on serum homocysteine concentrations in preeclampsia. Folia Biol (Praha). 2009;55(2):35-40.
  9. Kalay E, Ergen A, Narter F, Agaçhan B, Görmüs U, Yigit N, Isbir T. ARE-I polymorphism on PSA gene in prostate cancer patients of a Turkish population. Anticancer Res. 2009 Apr;29(4):1395-8.
  10. Narter KF, Ergen A, Agaçhan B, Görmüs U, Timirci O, Isbir T. Bladder cancer and polymorphisms of DNA repair genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1). Anticancer Res. 2009 Apr;29(4):1389-93.
  11. Aydogan HY, Isbir S, Kurnaz O, Gormus U, Isbir T. Associations of lipoprotein lipase S447X and apolipoprotein E genotypes with low-density lipoprotein subfractions in Turkish patients with coronary artery disease. In Vivo. 2009 Jan-Feb;23(1):155-61.
  12. Zejnilovic J, Akev N, Yilmaz H, Isbir T. Association between manganese superoxide dismutase polymorphism and risk of lung cancer. Cancer Genet Cytogenet. 2009 Feb;189(1):1-4.

 

İstanbul Üniversitesi © 2017 All Rights Reserved